FDA label
What is Neupro used for?
Neupro contains rotigotine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Neupro lists 2 uses: Parkinson's Disease (PD); Restless Legs Syndrome (RLS).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Neupro?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Neupro, patch, extended release
Indications and Usage, quoted from the label by UCB, Inc. (NDA021829). Cross-references to other label sections are left out.
Parkinson's Disease (PD)
NEUPRO is indicated for the treatment of Parkinson's disease.
Restless Legs Syndrome (RLS)
NEUPRO is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.
Source: DailyMed label, set id 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0, version 22, effective September 10, 2026. NDC 50474-801, one of 6 listings for this product.
Questions
What is Neupro used for?
The FDA label for Neupro lists 2 uses: Parkinson's Disease (PD); Restless Legs Syndrome (RLS).
What drug class is Neupro?
FDA lists rotigotine in the Nonergot Dopamine Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.